AlphaFold predicted structure
RD3 · Q7Z3Z2

Mean pLDDT
81.0/ 100
Confident
195 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)13%
- Low(50–70)32%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
RD3 regulator of GUCY2D
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Retinal disorders
BIALLELIC, autosomal or pseudoautosomalGlaucoma (developmental)
Ophthalmological ciliopathies
Primary ciliary disorders
Rare multisystem ciliopathy disorders
Skeletal dysplasia
Structural eye disease
BIALLELIC, autosomal or pseudoautosomalThoracic dystrophies
Leber congenital amaurosis 12
Leber congenital amaurosis
Retinal dystrophy
RD3-related retinopathy
eye disorder
Abnormality of the eye
hereditary disease
dysthymic disorder
major depressive disorder
mental disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Protein RD3
Plays a critical role in the regulation of enzymes involved in nucleotide cycle in photoreceptors (PubMed:21078983, PubMed:21928830, PubMed:27471269, PubMed:29515371, PubMed:30559291). Inhibits the basal catalytic activity and the GCAP-stimulated activity of GUCY2D and GUCY2F, two retinal guanylyl cyclases involved in the production of cGMP in photoreceptors (PubMed:21928830, PubMed:27471269, PubMed:29515371, PubMed:30559291). Involved in the transport of GUCY2D and GUCY2F to their target sites in the photoreceptor outer segment (PubMed:21078983). Up-regulates the activity of GUK1, a kinase that also plays an essential role for recycling GMP and indirectly, cGMP (PubMed:29515371). Plays an important role for the survival of rods and cones in the retina (By similarity)
RD3 · Q7Z3Z2

Mean pLDDT
81.0/ 100
Confident
195 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0